BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10622250)

  • 1. Insulin resistance and obesity.
    Schwartz MW; Kahn SE
    Nature; 1999 Dec 23-30; 402(6764):860-1. PubMed ID: 10622250
    [No Abstract]   [Full Text] [Related]  

  • 2. Free fatty acids--do they play a central role in type 2 diabetes?
    Arner P
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S11-9. PubMed ID: 11685824
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
    Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
    Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into insulin resistance and type 2 diabetes from knockout mouse models.
    Kadowaki T
    J Clin Invest; 2000 Aug; 106(4):459-65. PubMed ID: 10953020
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanisms by which PPAR gamma regulates fat storage and insulin sensitivity].
    Yamauchi T; Hara K; Miki H; Kadowaki T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():489-97. PubMed ID: 11351636
    [No Abstract]   [Full Text] [Related]  

  • 6. [PPAR family (PPAR alpha, PPAR delta, PPAR gamma)].
    Kamon J; Yamauchi T; Kadowaki T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():593-600. PubMed ID: 12238104
    [No Abstract]   [Full Text] [Related]  

  • 7. The Pro-115 --> Gln mutation in peroxisome-proliferator-activated receptor (PPAR) gamma2 is extremely rare in a large cohort of U.S. Caucasians.
    Terrett J; Chamberlain J; Rastan S; Marshall R; McGinnis R; Spurr N; O'Brien E; Evans C; Rut A
    Clin Sci (Lond); 2000 Jul; 99(1):89-90. PubMed ID: 10887062
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physiological function of peroxisome proliferator-activated receptor].
    Yanase T
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):443-7. PubMed ID: 10655664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P
    Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
    Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
    Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus issue: the signaling skinny on obesity.
    Chong LD; Adler EM; Ray LB
    Sci STKE; 2003 Feb; 2003(169):EG2. PubMed ID: 12582198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis of insulin resistance in IGT].
    Asakawa H; Tokunaga K
    Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
    Uauy R; Martínez JI; Rojas CV
    Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach.
    Bays H; Mandarino L; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):463-78. PubMed ID: 14764748
    [No Abstract]   [Full Text] [Related]  

  • 17. The Gly146Ala variation in human SF-1 gene: its association with insulin resistance and type 2 diabetes in Chinese.
    Liu W; Liu M; Fan W; Nawata H; Yanase T
    Diabetes Res Clin Pract; 2006 Sep; 73(3):322-8. PubMed ID: 16564598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.
    Pihlajamäki J; Vanhala M; Vanhala P; Laakso M
    Obes Res; 2004 Feb; 12(2):187-90. PubMed ID: 14981210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipotoxicity and the insulin resistance syndrome.
    Anderwald C; Roden M
    Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.